Official announcements
Recall
|
Medicines
|
31/03/2022
Precautionary recall due to reaching the specification limit
Enforcement
|
31/03/2022
The products called "Viarax classic" and "Viarax extralong" are marketed as natural dietary supplement especially for men. However, they have to be classified as illegal medicinal products.
Recall
|
Veterinary Medicines
|
25/03/2022
Recall due to leakage at the base of the injector
Enforcement
|
23/03/2022
The product called "Viazene Bleu" is marketed as an all-natural dietary supplement specifically for men. However, it is to be classified as an illegal medicinal product.
Enforcement
|
23/03/2022
The product called "Maxviril" is marketed as a purely herbal food supplement especially for men. However, it is to be classified as an illegal medicinal product.
CHMP Monthly News
|
17/03/2022
Up-to-date information from the 21.02-24.02.2022 meeting on new approvals, extensions of indication, newly published EPARs and recently started procedures.
CHMP Monthly News
|
17/03/2022
Up-to-date information from the 24.01.-27.01.2022 meeting on new approvals, extensions of indication, newly published EPARs and recently started procedures.
Recall
|
Medicines
|
08/03/2022
Recall due to nitrosamine contamination above the permitted daily dose
messages in brief
|
18/02/2022
Reporting suspected adverse reactions to veterinary drugs is possible using an online form.
messages in brief
|
14/02/2022
With the AMG amendment of 14.02.2022, § 21(2) was changed to the effect that the BASG must now be notified four months (instead of the previous two months) in advance of a temporary or permanent discontinuation of the marketing of medicinal products.